T1	Intervention 924 1055	with three parallel groups involving omega-3 fatty acid supplementation or sertraline hydrochloride, compared with matching placebo
T2	Intervention 1538 1688	At three months, subjects will undergo structural neuroimaging to assess whether treatment effects on depressive symptoms correlate with brain changes
T3	Intervention 1690 1827	Additionally, proton spectroscopy techniques will be used to capture brain-imaging markers of the biological effects of the interventions
